COMPARING SGLT2 INHIBITORS AGAINST SACUBITRIL/VALSARTAN IN HEART FAILURE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Teo, Yao Neng
Teo, Yao Hao
Syn, Nicholas L.
Yoong, Celine Shuen Yin
Cheong, Alex Jia Yang
Wee, Caitlin Fern
Lim, Yoke-Ching
Lee, Chi-Hang
Yeo, Tiong Cheng
Chai, Ping
Wong, Raymond Ching-Chiew
Lim, Weiqin
Sia, Ching Hui
机构：
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Natl Univ Heart Ctr Singapore, Singapore, Singapore
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3467 / 3467
页数：1
相关论文
共 50 条
  • [41] Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis
    Banerjee, Mainak
    Pal, Rimesh
    Mukhopadhyay, Satinath
    ACTA DIABETOLOGICA, 2022, 59 (06) : 783 - 791
  • [42] Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis
    Zhou, Peipei
    Tan, Ying
    Hao, Zhenning
    Xu, Weilong
    Zhou, Xiqiao
    Yu, Jiangyi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [43] The impact of SGLT2 inhibitors on inflammation: A systematic review and meta-analysis of studies in rodents
    Theofilis, Panagiotis
    Sagris, Marios
    Oikonomou, Evangelos
    Antonopoulos, Alexios S.
    Siasos, Gerasimos
    Tsioufis, Konstantinos
    Tousoulis, Dimitris
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [44] EFFECT OF SGLT2 INHIBITORS ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Usman, Muhammad Shariq
    Siddiqi, Tariq Jamal
    Coats, Andrew
    Rosano, Giuseppe
    Filippatos, Gerasimos
    Anker, Stefan D.
    Butler, Javed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 346 - 346
  • [45] Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
    Usman, Muhammad Shariq
    Bhatt, Deepak L.
    Hameed, Ishaque
    Anker, Stefan D.
    Cheng, Alice Y. Y.
    Hernandez, Adrian F.
    Jones, William Schuyler
    Khan, Muhammad Shahzeb
    Petrie, Mark C.
    Udell, Jacob A.
    Friede, Tim
    Butler, Javed
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 447 - 461
  • [46] Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis
    Hou, Jingjin
    Ren, Li
    Hou, Qingbin
    Jia, Xiaodong
    Mei, Zhu
    Xu, Jiaxin
    Yang, Zheming
    Li, Yiming
    Yan, Chenghui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [47] Heart Failure Prognosis in Diabetic Patients on SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors: A Systematic Review and Meta-Analysis
    Nso, Nso
    Emmanuel, Kelechi
    Nassar, Mahmoud
    Ayinde, Hakeem
    CIRCULATION, 2021, 144
  • [48] Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis
    Savage, Patrick
    Watson, Chris
    Coburn, Jaimie
    Cox, Brian
    Shahmohammadi, Michael
    Grieve, David
    Dixon, Lana
    ESC HEART FAILURE, 2024, 11 (06): : 3636 - 3648
  • [49] A systematic review and meta-analysis of SGLT-2 inhibitors in heart failure with a normal ejection fraction
    Singh, Surjit
    Shukla, Ravindra
    Sachin, J.
    Anil, Abhishek
    Dwivedi, Pradeep
    Varthya, Shoban Babu
    Kaur, Manbir
    Chugh, Vinay Kumar
    Khera, Daisy
    Chugh, Ankita
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 138 - 139
  • [50] Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
    Lee, Mei-Chuan
    Hua, Yi-Ming
    Yang, Chun-Ting
    Kuo, Fang-Hsiu
    Chang, Wei-Ting
    Tang, Hsin-Ju
    Toh, Han Siong
    Lin, Yu-Min
    Chen, Sih-Yao
    Chang, Hung-Yu
    Liao, Chia-Te
    MEDICINE, 2022, 101 (51) : E32489
12345